Humane Cosmetics Act of 2025
Summary
What This Bill Does
The Humane Cosmetics Act creates a federal ban on most cosmetic animal testing and on selling cosmetics tied to new animal testing. One year after enactment, companies may not knowingly conduct or contract for cosmetic animal testing in the United States. They also may not knowingly sell, offer for sale, or transport in interstate commerce a cosmetic product developed or manufactured using cosmetic animal testing conducted or contracted for after that date by anyone in the product's supply chain. New animal-test evidence generally cannot be used to establish cosmetic safety unless an exemption applies, such as when no recognized non-animal alternative exists and the testing responds to a non-cosmetic regulatory need. FDA receives enforcement and exemption responsibilities, while cosmetics firms must move safety substantiation toward non-animal methods.
Who Benefits and How
Animal welfare organizations benefit because the bill bans routine cosmetic animal testing and sale of cosmetics tied to new animal testing. Consumers seeking cruelty-free cosmetics benefit from federal rules that reduce animal-tested products in interstate commerce. Cosmetics companies using non-animal methods benefit from a clearer national standard that rewards alternative testing strategies. Alternative testing laboratories benefit from increased demand for recognized non-animal safety methods.
Who Bears the Burden and How
Cosmetics manufacturers must audit supply chains and safety substantiation to avoid post-enactment animal testing. Cosmetic ingredient suppliers must shift evidence strategies or qualify for FDA-recognized exemptions. Food and Drug Administration staff must administer exemptions and enforce sale and testing restrictions. Companies relying on animal-test data face market-access limits and compliance risk for affected cosmetics.
Key Provisions
- Prohibits knowingly conducting or contracting for cosmetic animal testing in the United States.
- Bars interstate sale or transport of cosmetics developed with covered post-enactment animal testing.
- Limits reliance on new animal-test evidence to establish cosmetic safety.
- Provides exemptions when no recognized non-animal alternative exists or another regulatory law requires testing.
- Requires FDA enforcement of testing, sale, and exemption rules.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Prohibits cosmetic animal testing in the United States, bars interstate sale of cosmetics developed with post-enactment animal testing, limits reliance on new animal-test evidence, and creates FDA-supervised exemptions.
Key Policy Areas
Animal Welfare, Cosmetics, Consumer Product Safety
Primary Purpose
Prohibits cosmetic animal testing in the United States, bars interstate sale of cosmetics developed with post-enactment animal testing, limits reliance on new animal-test evidence, and creates FDA-supervised exemptions.
Policy Domains
Resolution provisions
Identified Gains
- Animal welfare organizations
- Cruelty-free consumers
- Cosmetics companies
- Alternative testing laboratories
Identified Costs
- Cosmetics manufacturers
- Cosmetic ingredient suppliers
- Food and Drug Administration
- Animal-testing laboratories
Sponsors
Legislative Progress
In CommitteeMr. Beyer (for himself, Mr. Buchanan, Mr. Tonko, Mr. Calvert, …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology